Home » KEYNOTE-564: Pembrolizumab as Adjuvant Therapy

KEYNOTE-564: Pembrolizumab as Adjuvant Therapy

by Moshe Ornstein, MD, MA, Karine Tawagi, MD, Hans Hammers, MD, Mahdi Taha, DO, FACOI, FACP & Nataliya Mar, MD | Sep 27, 2024 | Articles | 0 Comments